Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2017.137
Full Text
Open PDFAbstract
Available in full text
Date
May 16, 2017
Authors
Publisher
Springer Science and Business Media LLC